Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C1NU
|
||||
| Former ID |
DNC014783
|
||||
| Drug Name |
N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528617] | ||
| Formula |
C14H10Cl2N2O3
|
||||
| Canonical SMILES |
CC1=C(C=CC=C1[N+](=O)[O-])C(=O)NC2=CC(=CC(=C2)Cl)Cl
|
||||
| InChI |
1S/C14H10Cl2N2O3/c1-8-12(3-2-4-13(8)18(20)21)14(19)17-11-6-9(15)5-10(16)7-11/h2-7H,1H3,(H,17,19)
|
||||
| InChIKey |
NKIJNFMSYDSAJK-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dihydroorotate dehydrogenase, mitochondrial | Target Info | Inhibitor | [528617] | |
| KEGG Pathway | Pyrimidine metabolism | ||||
| Metabolic pathways | |||||
| PathWhiz Pathway | Pyrimidine Metabolism | ||||
| Reactome | Pyrimidine biosynthesis | ||||
| WikiPathways | Metabolism of nucleotides | ||||
| References | |||||